Heron Therapeutics partners with CrossLink for ZYNRELEF sales
[ad_1] SAN DIEGO – Heron Therapeutics, Inc. (NASDAQ:), a commercial-stage biotech company, has announced a new partnership with CrossLink Life Sciences, LLC to enhance the distribution of its postoperative pain management solution, ZYNRELEF®. The collaboration,